Oral fish scale collagen peptides protected mice from UVB-induced wrinkles and skin damage over 12 weeks, with the active dipeptides Gly-Pro and Pro-Hyp confirmed in blood plasma after ingestion.
12 weeks protectionOral fish collagen peptides significantly reduced UVB-induced wrinkles, water loss, and skin thickening in hairless mice
What the researchers found
Fish scale collagen peptide NS (CPNS) was characterized with Gly-Pro identified as a representative bioactive dipeptide. Key findings:
- In cell culture: CPNS reduced MMP-1 (collagen-degrading enzyme) production and increased type 1 procollagen synthesis in human dermal fibroblasts
- In rats: Oral CPNS dramatically increased plasma concentrations of Gly-Pro and Pro-Hyp, confirming bioavailability
- In 12-week hairless mouse study: Oral CPNS significantly attenuated UVB-induced wrinkle formation, reduced transepidermal water loss, decreased epidermis thickening, and increased skin hydration compared to UV-exposed controls
Why it matters
Collagen supplements are a multibillion-dollar industry, but the mechanism of oral collagen benefits has been debated. This study provides concrete evidence that specific dipeptides from collagen actually reach the bloodstream and that oral supplementation protects against UV-induced skin aging in a controlled animal model.
How the study worked
CPNS from fish scale was characterized by prep-HPLC and LC-MS/MS. In vitro effects were tested on human dermal fibroblasts. Oral bioavailability was confirmed by measuring plasma dipeptide levels in rats after CPNS ingestion. In vivo photoprotection was assessed in hairless mice exposed to UVB for 12 weeks while receiving oral CPNS supplementation.
What this study cannot tell us
Animal study in hairless mice — UV response and skin structure differ from human skin. The UV exposure protocol was artificial and may not perfectly model real-world sun damage. Only fish scale collagen was tested; results may differ for bovine or marine collagen from other sources. No human clinical trial data was presented. Specific dosing information relative to typical human supplement doses wasn't detailed.
How to read the evidence
This is a preclinical study combining in vitro, pharmacokinetic, and in vivo experiments. While comprehensive for an animal study, the evidence is not directly applicable to human supplement recommendations without clinical trial confirmation.
When this study was published
Published in 2019 in Bioscience, Biotechnology, and Biochemistry. The findings contributed to the growing scientific basis for collagen supplementation that has continued to develop since.
The bigger picture
The collagen peptide supplement market has long been criticized for lacking mechanistic evidence. This study addresses that gap by identifying the specific bioactive peptides that survive digestion and reach the bloodstream, and demonstrating their functional effects on UV-damaged skin. This type of mechanistic validation is needed to move collagen supplements from consumer marketing claims to evidence-based recommendations.
Questions still open
- Do the blood levels of Gly-Pro and Pro-Hyp achieved in rats translate to similar levels in humans taking standard collagen supplement doses?
- Would these collagen dipeptides show the same photoprotective effects in human skin aging studies?
- How do the bioactive peptide profiles differ between fish, bovine, and marine collagen supplements?
Common questions
Do collagen supplements actually get absorbed into the body?
Can collagen pills protect against sun damage?
Read the original research
Orally administered collagen peptide protects against UVB-induced skin aging through the absorption of dipeptide forms, Gly-Pro and Pro-Hyp.
Bioscience, biotechnology, and biochemistry, 83(6), 1146-1156
Citation
Lee, Hyun-Jun; Jang, Hye-Lim; Ahn, Dong-Kyu; Kim, Hun-Jung; Jeon, Hee Young; Seo, Dae Bang; Lee, Ji-Hae; Choi, Jin Kyu; Kang, Seok-Seong. (2019). Orally administered collagen peptide protects against UVB-induced skin aging through the absorption of dipeptide forms, Gly-Pro and Pro-Hyp.. Bioscience, biotechnology, and biochemistry, 83(6), 1146-1156. https://doi.org/10.1080/09168451.2019.1580559